ストックスクリーナーアプリを入手
2.93
1.35%
-0.04
アフターアワーズ：
2.89
-0.04
-1.37%
前日終値:
$2.97
開ける：
$2.93
24時間の取引高:
100.32K
Relative Volume:
0.16
時価総額：
$5.86M
収益：
$32.96M
当期純損益:
$-4.23M
株価収益率:
-0.0189
EPS:
-155.3294
ネットキャッシュフロー:
$-14.00M
1週間 パフォーマンス:
-15.32%
1か月 パフォーマンス:
+1.38%
6か月 パフォーマンス:
-57.44%
1年 パフォーマンス:
-99.41%
1日の値動き範囲:
$2.85
$3.10
1週間の範囲:
$2.85
$3.47
52週間の値動き範囲:
$2.1056
$571.20
Sunshine Biopharma Inc Stock (SBFM) Company Profile
名前
Sunshine Biopharma Inc
セクター
電話
954-515-0810
住所
333 LAS OLAS WAY, FORT LAUDERDALE
SBFM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
2.93 | 5.86M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
163.32 | 73.68B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.10 | 41.15B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.95 | 41.06B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.94 | 23.73B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
140.90 | 14.27B | 2.24B | 385.90M | 440.10M | 3.73 |
Sunshine Biopharma Inc (SBFM) 最新ニュース
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Down 14.6% in December - Defense World
Sunshine Biopharma Inc. Elects New Directors and Ratifies Appointment of Independent Registered Public Accounting Firm - Defense World
Sunshine Biopharma re-elects board, ratifies CPA firm By Investing.com - Investing.com Nigeria
Sunshine Biopharma re-elects board, ratifies CPA firm - Investing.com India
Sunshine Biopharma’s PLpro inhibitor shows activity in SARS-CoV-2 - BioWorld Online
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus - AccessWire
Sunshine Biopharma's Novel COVID-19 Oral Treatment Shows Breakthrough Antiviral Activity in Preclinical Study - StockTitan
Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga
Sunshine Biopharma Launches a New Generic Prescription Drug - AccessWire
Sunshine Biopharma Launches Generic Allergy Drug in $1.3B Global Bilastine Market - StockTitan
Mouse model studies provide proof of concept for Sunshine Biopharma’s K1.1 mRNA product for HCC - BioWorld Online
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma - AccessWire
Sunshine Biopharma's K1.1 mRNA Shows Breakthrough Results in Liver Cancer Treatment - StockTitan
SBFM (Sunshine Biopharma) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Operating Income : $-4.91 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Change In Working Capital : $-7.80 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Debt-to-Equity : 0.02 (As of Sep. 2024) - GuruFocus.com
Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com
Stock market today: SKK Holdings Limited +81.83%, Palladyne AI Corp. +50.51% among top gainers in early trading - Business Upturn
Sunshine Biopharma launches generic prescription drug - TipRanks
Sunshine Biopharma launches generic liver drug in Canada - Investing.com
Sunshine Biopharma Launches New Generic Drug in $933M Growing Market | SBFM Stock News - StockTitan
Sunshine Biopharma stock hits 52-week low at $2.3 amid sharp decline - Investing.com Canada
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com
Sunshine Biopharma Inc. Warrant (SBFMW) Quarterly 10-Q Report - Quartz
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - AccessWire
Sunshine Biopharma Q3 Revenue Surges 42% to $8.4M Despite Widening Losses - StockTitan
SBFM (Sunshine Biopharma) Shares Outstanding (EOP) : 1.17 Mil (As of Jun. 2024) - GuruFocus.com
Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com
Bloomin’ Brands (NASDAQ:BLMN) Rating Increased to Hold at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
First Citizens Bancshares (OTC:FIZN) Stock Price Down 4.3% – Should You Sell? - Defense World
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
JATT Acquisition (NYSE:JATT) Trading Down 2.7% – Should You Sell? - Defense World
Sunshine Biopharma Strengthens Leadership with New Executive Agreements - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September - MarketBeat
Sunshine Biopharma meets Nasdaq compliance requirements By Investing.com - Investing.com Nigeria
Sunshine Biopharma announces Nora Pharma launch of two new generic drugs - TipRanks
Sunshine Biopharma expands generic drug portfolio - Investing.com
Sunshine Biopharma’s Nora Pharma launches two generic prescription drugs - TipRanks
Sunshine Biopharma Launches Two New Generic Prescription Drugs - AccessWire
A new trading data show Sunshine Biopharma Inc (SBFM) is showing positive returns. - SETE News
Sunshine Biopharma Inc (SBFM) Stock: Navigating a Year of Volatility - The InvestChronicle
How is SBFM’s stock performing after recent trades? - US Post News
Sunshine Biopharma meets Nasdaq compliance requirements - Investing.com
Sunshine Biopharma announces publication of coronavirus research results - TipRanks
Sunshine Biopharma reports potential SARS-CoV-2 treatment By Investing.com - Investing.com Canada
Sunshine Biopharma reports potential SARS-CoV-2 treatment - Investing.com
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry - Lelezard
Sunshine Biopharma Inc (SBFM) 財務データ
収益
当期純利益
現金流量
EPS
1.04%
2.00%
大文字化:
|
ボリューム (24 時間):